Selective portal vein occlusion with hepatic artery preservation reduces posthepatectomy liver failure: a retrospective cohort study

Jiming Ma, Jingyu Wang, Liuqing Yang, Bingjun Tang, Canhong Xiang, Qiang Li, Pengfei Wang, Nan Jiang, Jianping Song, Yumei Li, Dongliang Yang, Yan Wen, Xuedong Wang, Shuo Jin, Jiahong DongInternational Journal of Surgery 2025 · DOI

TL;DR

This study introduces and validates a novel surgical technique, Selective Portal Vein Occlusion (SPO) with Hepatic Artery Preservation, for liver resections. SPO significantly reduces the incidence of posthepatectomy liver failure (PHLF) compared to the traditional Pringle maneuver, without increasing intraoperative bleeding or complications, offering a safer approach for liver surgery.

What Problem Does This Paper Address?

Liver resections, while crucial for treating liver diseases, carry a significant risk of posthepatectomy liver failure (PHLF), often stemming from ischemia-reperfusion (I/R) injury. Current methods to control bleeding during these surgeries, primarily hepatic inflow occlusion techniques like the Pringle maneuver, have limitations. The Pringle maneuver, while effective for bleeding control, can lead to I/R injury due to complete occlusion of both the portal vein and hepatic artery. This injury is exacerbated in patients with compromised liver function (e.g., cirrhosis), where the hepatic artery plays a more critical role in oxygen supply. The challenge is to find a method that effectively controls bleeding while minimizing I/R injury, especially in vulnerable patient populations.

Methods

This retrospective cohort study compared two hepatic inflow occlusion techniques: Selective Portal Vein Occlusion (SPO) with hepatic artery preservation, and the traditional Pringle maneuver.

  • Propensity Score Matching (PSM): To minimize selection bias and confounding factors, patients were matched 1:1 based on key baseline characteristics (sex, age, BMI, Child-Pugh score). This ensured that the groups being compared were as similar as possible, allowing for a more accurate assessment of the occlusion techniques' impact.
  • Data Collection: Detailed clinical and perioperative data were collected from patients undergoing hepatectomy between 2014 and 2024. This included patient demographics, surgical details (occlusion type, duration, blood loss), and postoperative outcomes (PHLF, complications, mortality).
  • Statistical Analysis:
    • Univariate and Multivariate Logistic Regression: Used to identify independent risk factors for PHLF and the protective effect of SPO.
  • Receiver Operating Characteristic (ROC) Analysis: Employed to determine the predictive value of Indocyanine Green retention rate at 15 minutes (ICG-R15) for PHLF and establish an optimal cut-off value.
  • Subgroup Analyses: Conducted to identify specific patient populations that might benefit more from SPO.

Datasets

The study utilized retrospective clinical data from 574 patients who underwent hepatectomy at a single institution between 2014 and 2024. After PSM, 384 patients (192 in the SPO group and 192 in the Pringle group) were included in the final analysis. No new datasets or benchmarks were introduced.

Key Insights and Ideas

  • The Hepatic Artery is Crucial: The study highlights the critical role of the hepatic artery in oxygenating the liver, especially in patients with compromised liver function. Preserving this flow while occluding the portal vein offers a more nuanced approach to I/R injury mitigation.
  • SPO as a Protective Factor: SPO emerged as an independent protective factor against PHLF, suggesting it's not just about reducing blood loss but also about preserving vital liver function.
  • Targeted Benefits: The subgroup analyses revealed that SPO offers particularly significant benefits for younger patients (<60 years), males, those with a BMI ≥ 23, non-cirrhotic patients, those with benign liver diseases, and patients undergoing less extensive resections (≤ hemihepatectomy). This suggests SPO might be a more tailored approach for specific patient profiles.
  • ICG-R15 as a Predictive Tool: The study confirmed ICG-R15 as a valuable predictor of PHLF, with a well-defined optimal cut-off value, aiding in preoperative risk assessment.

Key Results

  • Reduced PHLF: The SPO group had a significantly lower incidence of PHLF (3.1%) compared to the Pringle group (10.4%, P = 0.026).
  • Comparable Complications: There were no statistically significant differences in other major complications, including postoperative hemorrhage (POH), bile leakage, infection, or Clavien-Dindo grade III-IV complications, between the two groups.
  • No Increased Surgical Time or Blood Loss: While the dissection for SPO might be slightly more complex, the study found no statistically significant increase in overall surgery time or intraoperative blood loss compared to the Pringle maneuver.
  • Improved Postoperative Liver Function Markers: Laboratory tests like AST, ALT, and BNP showed significantly lower levels in the SPO group on early postoperative days, indicating less liver injury and potentially better cardiac function.
  • ICG-R15 Prediction: The ROC analysis identified an optimal cut-off value of 6.9% for ICG-R15 to predict PHLF, with high sensitivity (88.5%) and reasonable specificity (66.5%).
  • Independent Risk Factors for PHLF: Blood loss, ICG-R15 > 0.069, and undergoing > hemihepatectomy were identified as independent risk factors for PHLF.

Limitations and Future Work

  • Retrospective Design and Single Center: The study's retrospective nature and data collection from a single institution are acknowledged limitations, potentially introducing selection bias and limiting generalizability.
  • Sample Size: The study noted that the relatively small and homogeneous sample size might have contributed to the lack of a significant association between ischemic duration and PHLF, despite existing literature suggesting otherwise.
  • Missing Data: The retrospective data collection led to some missing information, which could have affected the comprehensiveness of the findings.
  • External Validation: The absence of external validation for the findings weakens their reliability.

Future Work: The authors propose conducting multicenter prospective randomized controlled trials to obtain more objective results and further validate the efficacy of the SPO technique. They also emphasize the need for experienced surgeons to perform SPO, especially in large hepatobiliary centers, and for younger surgeons to gain extensive practice. Further research is also suggested to explore the potential protective effects of SPO on other organs by reducing circulatory fluctuations.

Summary updated

Abstract

The occlusion approach of SPO while preserving hepatic arterial flow can significantly reduce the incidence of PHLF.
BibTeX
@article{ma2025selective,
  author = {Jiming Ma and Jingyu Wang and Liuqing Yang and Bingjun Tang and Canhong Xiang and Qiang Li and Pengfei Wang and Nan Jiang and Jianping Song and Yumei Li and Dongliang Yang and Yan Wen and Xuedong Wang and Shuo Jin and Jiahong Dong},
  title = {{Selective portal vein occlusion with hepatic artery preservation reduces posthepatectomy liver failure: a retrospective cohort study}},
  journal = {International Journal of Surgery},
  year = {2025},
  doi = {10.1097/js9.0000000000003548},
}
Figure